Semaglutide GLP-1 has been shown to significantly reduce body weight, improve blood sugar control, and reduce waist circumference
Further investigations are needed to elucidate the specific mis-spliced genes and proteins directly influenced by SF3B1 mutations together with the crosstalk between SF3B1 and MAPK pathway in tumorigenesis of MM, and the findings may provide a new perspective for targeted therapy
Offer is for 2 monthly fills through December 31, 2026, then $349 per month for Wegovy 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, or 2.4 mg, and $399 per month for Wegovy HD (semaglutide) injection 7.2 mg
If you are prone to sleep disturbances on GLP-1 therapy , evening injection might worsen the problem rather than solve it
Evidence Gaps: Most positive findings come from topical formulations or small studies